Current Management and Outcome of Pregnancies in Women With Adrenal Insufficiency: Experience from a Multicenter Survey
- 1 August 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (8), e2853-e2863
- https://doi.org/10.1210/clinem/dgaa266
Abstract
Context Appropriate management of adrenal insufficiency (AI) in pregnancy can be challenging due to the rarity of the disease and lack of evidence-based recommendations to guide glucocorticoid- and mineralocorticoid dosage adjustment. Objective Multi-center survey on current clinical approaches in managing AI during pregnancy. Design Retrospective anonymized data collection from 19 international centers from 2013-2019. Setting and Patients 128 pregnancies in 113 women with different causes of AI: Addison disease (44%), secondary AI (25%), congenital adrenal hyperplasia (25%) and acquired AI due to bilateral adrenalectomy (6%). Results Hydrocortisone (HC) was the most commonly used glucocorticoid in 82.9% (97/117) of pregnancies. Glucocorticoid dosage was increased at any time during pregnancy in 73/128 (57%) of cases. In these cases, difference of the daily dose of HC equivalent between baseline and the third trimester was 8.6±5.4 [range: 1, 30] mg. Fludrocortisone dosage was increased in fewer cases (7/54 during the first trimester, 9/64 during the second trimester and 9/62 cases during the last trimester). Overall, an adrenal crisis was reported in 9/128 (7%) pregnancies. Caesarian section was the most frequent mode of delivery at 58% (69/118). Fetal complications were reported in 3/120 (2.5%) and minor maternal complications in 15/120 (12.5%) pregnancies without fatal outcomes. Conclusions This survey confirms good maternal and fetal outcome in women with AI managed in specialized endocrine centers. An emphasis on careful endocrine follow up and repeated patient education is likely to have reduced the risk of adrenal crisis and resulted in positive outcomes.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft
- James A. Ruppe Career Development Award in Endocrinology
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health (K23DK121888)
This publication has 28 references indexed in Scilit:
- Changes in the Maternal Hypothalamic-Pituitary-Adrenal Axis in Pregnancy and Postpartum: Influences on Maternal and Fetal OutcomesNeuroendocrinology, 2013
- What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?Clinical Endocrinology, 2012
- Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiencyActa Endocrinologica, 2012
- A systematic review to calculate background miscarriage rates using life table analysisBirth Defects Research Part A: Clinical and Molecular Teratology, 2012
- Autoimmune polyglandular syndromesNature Reviews Endocrinology, 2010
- Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiencyClinical Endocrinology, 2008
- Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiencyHuman Reproduction, 2008
- Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potencyThe Journal of Pediatrics, 2003
- Effects of estrogens and progestogens on the renin-aldosterone system and blood pressureSteroids, 1996
- Incidence of Early Loss of PregnancyThe New England Journal of Medicine, 1988